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Choices in Breast Cancer Treatment
Marek K. Dobke, MD, PhD,* Brittany Yee, MD,* Gina A. Mackert, MD,†
William Y. Zhu, BA,* and Sarah L. Blair, MD‡Background: The landscape of surgical and medical management and patient
choices for breast cancer treatment changes as breast reconstruction and oncoplastic
approaches improve and diversify. Increased access to breast reconstruction, in
addition to patient education, influences the breast cancer patient. Therefore,
the examination of the possible impact of reconstructive surgery on all stages
of the breast cancer management per se seemed timely.
Methods: Plastic surgery consults were arranged for 520 new patients diagnosed
with breast cancer (2012–2016) including patients with noninvasive breast cancer
but at high risk of further cancer development. To test the plastic surgery impact
on patient choices regarding the management of the cancer, a subset of 90 patients
was identified to test the plastic surgery impact on patient choices. These patients
were referred to plastic surgery, following the first round of consultations by
surgical and medical oncologists with only the preliminary oncological management
plan defined.After a plastic surgery consultation, but prior to finalization of the overall
oncological management plan, theywere surveyed on the subject of modification of
their personal choices and requests pertaining to their cancer management.
Results: In this subset of 90 patients 40 (44%) returned to their surgical or med-
ical oncologist considering changes of the primary management plan after their
plastic surgery consultation. Twenty-six (28%) ultimately altered their plan, and
the following patient-driven changesweremade: mastectomy as opposed to lump-
ectomy (18 patients [20%]), contralateral prophylactic mastectomy (11 patients
[12%]), nipple/areola removal as opposed to nipple/areola sparing suggested by
the oncologists (5 patients [6%]), oncoplastic breast reduction as part of lumpec-
tomy (5 patients [6%]), and other modifications (3 patients [3%]).
Conclusions:Decisions for altering the preliminary oncologic plan or choosing a
specific alternative (eg, lumpectomy plus radiation vs mastectomy) resulted from
patient education on (1) reconstructive options, (2) aesthetic pitfalls and results. and
(3) their interfacing with the oncological outcomes. Ultimately, plastic surgeons in-
fluence the multispecialty breast cancer management and patient decision-making
process. Therefore, oncological literacy for plastic surgeons is essential to provide
state-of-the-art breast cancer care and avoidance of suboptimal patient decisions.
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206 www.annalsplasticsurgery.comF or decades, breast reconstructive approaches were dependent onchanges in breast cancer treatment and attitudes of general surgeons
and were unfavorable for breast reconstruction concepts.1 Changes in
attitudes occurred in the 1970s, when new reconstructive techniques
made breast reconstruction safe and relatively successful, when it was
recognized that reconstruction does not promote metastases or delays
in the discovery of recurrences.1,2 However, with respect to the endorse-
ment of breast reconstruction, for a long time, general surgeons fre-
quently took the “do not ask/do not tell” approach.1–3
In fact, postmastectomy breast reconstruction has come a long
way since first described in 1885 by Vincenz Czerny, a professor at
the University of Heidelberg in Germany. First volumes on breast
reconstruction techniques were published in the late 1970s and early
1980s.4 However, concurrently in the 1980s and 1990s, mastectomy
rates fell as breast conservation became more widely accepted.5 On
the other hand, in the 2000s, increasing rates of mastectomies have been
noted—even when breast conservation was a viable oncologic option.6,7
Today, breast cancer patients are influenced by the advent of new
oncoplastic approaches and operative techniques including microsur-
gery, improvements in tissue expansion, and breast implant technology,
as well as public education, breast reconstruction advocacy, and access
to reconstruction. These developments have conceivably contributed to
changing the landscape of surgical management including raising inter-
est in reconstructive options for partial breast defects.1,2,5,8–11
Many previously conducted studies illuminated oncological and
patient-based variables affecting the choice and conduction of breast
reconstruction.1,2,10–12 However, little is known about how an increased
participation of plastic surgeons, inmany aspects of breast care, impacts
patient's decisions in terms of breast cancer treatment. Therefore, the ex-
amination of a possible new paradigm and the reversal of the “traditional”
direction of influence seemed timely. Specifically, evaluation of the possi-
ble impact of breast reconstruction and its extent on breast cancer manage-
ment per se, including shared decisions, was the objective of this study.1,2METHODS
The University of California San Diego Comprehensive Breast
Health Care Program offers patients full access to all aspects of breast
care with a low rate of disparities. Historically (2009–2016), meta-
chronous plastic surgery consults were arranged for 50% of new
patients, including patients with noninvasive breast cancer but at high
risk of further cancer development. The other 50% reconstructive consults
were rendered concurrently, during the same clinical session, with oncolog-
ical consults. Program patients seen by dual-trained surgeons (plastic and
oncological surgery) were excluded from this analysis.12 Overall, this
program, which averages an overall reconstruction rate of 68%, offers
a credible and unique base of data to investigate how the exposure to
breast reconstruction options impacts diverse patient choices pertaining
to the management of the cancer itself without care access bias.12
The University of California San Diego physician-billing data-
base revealed that a total of 520 patientswith primary diagnosis of breastAnnals of Plastic Surgery • Volume 83, Number 2, August 2019
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tween 2012 and 2016. A single-institution survey-based analysis was
conducted investigating rates and types of patient's initial decision, de-
cision change, or opting for a specific alternative with respect to cancer
treatment after plastic surgery consultation. To test the plastic surgery
impact, patients with recent (<4 weeks) diagnosis of primary breast can-
cer were included in the study. Following consultations by surgical and
medical oncologists, patients with a defined preliminary treatment plan
consulted with a plastic surgeon in person (in a geographically different
clinic and on another day than the oncological consultations took
place). Subsequently, these patients returned to oncologists to rediscuss
and conclude the management plan (Fig. 1).
A subset of 90 patients were identified. These patients were diag-
nosed with primary breast cancer and had a preliminary defined onco-
logical management plan and were in consideration of immediate breast
reconstruction, including the possibility of joint oncoplastic procedures
prior to their plastic surgery consultation. Patients were surveyed re-
garding anymodification of their original personal choices and requests
following plastic surgery consultation and prior to finalization of the
overall oncological management plan (Fig. 2). The institutional review
board at the University of California San Diego provided ethics ap-
proval for the study (130050).RESULTS
Patient ages ranged from 23 to 88 years (mean 53.5 years). The
subjects of this study were a subset of 90 patients who had a prelimi-
nary, tentative surgical treatment plan after the first round of oncologi-
cal consultations and who consulted with a plastic surgeon prior to the
finalization of the oncological management plan. Program patients
managed surgically by a dual-trained surgeon (surgical oncology and
plastic surgery) were not included. Patients in this group presented at
various malignancy stages. Cancer classification stages per the
American Joint Committee included carcinoma in situ (19 [21.1%]),
stage I (30 [33.3%]), stage II (20 [22.2%]), stage III (18 [20%]), and
stage IV (3 [3.3%]). After their plastic surgery consultation, all patients
returned to their oncologists. After their plastic surgery consultation,
40 patients (44%) returned to their surgical or medical oncologist con-
sidering or requesting changes of the preliminary breast cancer manage-
ment plan. Reported requests to alter the preliminary surgical plan or to
choose a specific alternative of oncological surgery were as follows:
mastectomy versus lumpectomy or quadrantectomy, 18 (20%); contra-
lateral prophylactic mastectomy versus unilateral therapeutic mastec-
tomy, 11 (12.2%); nipple/areola complex removal versus nipple/areola
complex sparing surgery, 5 (5.5%); oncoplastic breast reduction or
contouring with partial mastectomy versus lumpectomy alone, 5 (5.5%);
and other in 3 cases (3.3.%). In the category of “other,” choices in-
cluded the following: 2 patients opted for tissue transfer (flaps) with
implantation of brachytherapy catheters and the removal of theFIGURE 1. The sequencing of appointments: all consultations
took place in a geographically different setting and on different
dates.
© 2018 The Author(s). Published by Wolters Kluwer Health, Inc.contralateral breast implant, placed for cosmetic indications by the pa-
tient prepared otherwise for lumpectomy. Two patients requested more
than 1 change. Specific requests are summarized in Table 1. Whenever
possible, the patient's reasoning was ascertained (both from survey data
and medical records). The most frequently reported reasoning for
opting toward mastectomy and prophylactic mastectomy was the
awareness of outcomes of total breast reconstruction in the context of
positive tests for BRCA1 (8 patients [8.9%]), BRCA2 (6 patients
[6.7%]), or both (6 patients [6.7%]); early onset of cancer (5 patients
[5.6%]); triple-negative status (6 patients [6.7%]); and/or multiple rela-
tiveswith breast cancer (25 patients [28%]).7,8,13,14 None of the patients
indicated that the plastic surgeon provided different information related
to outcomes and risks. Education provided by the plastic surgeon was
perceived as affirmation or expansion of earlier information within
the final expected aesthetic outcome perspective.
Several patients (32 patients [35.6%]) indicated that they
benefited from the plastic surgeon's guidance regarding the implica-
tions of variations in the definition of “safe” or appropriate margins in
breast conservation surgery associated with volume of breast surgery
and contour changes.15 In 2 cases, patients who decided on contralateral
prophylactic mastectomy quoted the plastic surgeon's statement that “in
cases of bilateral autologous transverse rectus abdominis myocutaneous
flap-based reconstructions, it is easier to achieve symmetry if recon-
struction is performed at the same time” (Fig. 3). Circumstances ofmeta-
chronous disease sometimes exemplify and support this perspective.16
Requests to resect the nipple/areola complex and de novo resto-
ration either surgically or by means of a 3-dimensional tattoo technique
stemmed from patient education on adverse outcomes of nipple/areola
complex–sparing mastectomy.8,17 Quoted adverse outcomes include
lack of spared nipple sensitivity, the potential for occasional complex
malposition, nipple(s) inversion, nipple loss, and the prospect of a “delayed”
procedure, especially in patients with large, pendulous breast. Requests for
oncoplastic breast reduction or other forms of breast shape–conserving sur-
gical techniques were all related to patient appreciation of presented results
(including good, average, and with challenging problems).8,9,18DISCUSSION
Modern, personalized, effective breast cancer treatment needs
providerswith diverse expertise and skills. The comprehensive manage-
ment of breast cancer must consider different circumstances that
patients will have to cope with including the logistical, social, and cul-
tural aspects of breast care. Different specialist providers involved
impact each other, and evidence suggests that patients can grasp on
sometimes contradictory concepts and recommendations and reason-
ably participate in sharing the decision-making process in designing
and planning their cancer management.19,20 Certainly, regional and cul-
tural environments could impact not only patient decisions but also the
style of health care information; therefore, decision tools may not be
uniform. However, this report was created at the same institution and
practice environment as previous ones; therefore, we believe that the
ideas are comparable.1,12,19,21 The University of California San Diego
Comprehensive Breast Health Center Program, with approximately a
100% rate of patient access to all aspects of breast care and rate of dis-
parities, offered a credible base to investigate how exposure to breast
reconstruction impacts choices without care access bias.12 The impact
of external-to-oncological specialists on patient breast cancer treatment
decisions is not exclusively related to plastic surgeons.22,23 Overall
trends toward the increase in the rate of some procedures such as con-
tralateral prophylactic mastectomy are poorly understood. The rise in
rate of mastectomies can be, to a degree, attributed to media (maga-
zines, TV shows) or online sources (eg, WebMD, American Cancer
Society) all impacting public awareness and causing a fear of recurrence
despite the lack of evidence regarding the oncological outcome and
long-term prognosis.7,10,24www.annalsplasticsurgery.com 207
FIGURE 2. Survey questionnaires were provided to individual patients after the plastic surgery consultation with the request to
complete and return them after the second visit with their medical/surgical oncologist. The survey requested submission of
demographic data (eg, age, personal history of breast cancer, family history of breast cancer, genetic testing, BRCA status if known to
the patient, understanding of preoperative magnetic resonance imaging, knowledge of additional abnormal findings [ipsilateral,
contralateral], patient's comprehension of the index cancer requiring surgery, and knowledge of the cancer pathology [invasive ductal,
lobular, ductal carcinoma in situ, mixed, known lymph node status]). The data were verified by the content of the patient's medical
records.
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TABLE 1. Patient-Reported Alteration of the Preliminary Surgical Plan After Plastic Surgery Consultation
Variable No. (%) Requested Changes
Mastectomy as opposed to lumpectomy or quadrantectomy 18 (20)
Contralateral prophylactic mastectomy as opposed to unilateral therapeutic mastectomy 11 (12)
Nipple/areola removal as opposed to nipple/areola sparing 5 (6)
Oncoplastic breast reduction or contouring with lumpectomy as opposed to lumpectomy only 5 (6)
Other 3 (3)
Total amount of changes requested by the 40 patients 42
Two patients requested more than 1 change.
Annals of Plastic Surgery • Volume 83, Number 2, August 2019 Breast Cancer Treatment ChoicesPerhaps the very high satisfaction rate (93%) amongwomenwho
opted to undergo contralateral prophylactic mastectomy regardless
of whether it was oncologically indicated is related to “decision co-
ownership” as demonstrated by 2 of our patients.25
Patient education before the commencement of cancer treatment
influences the rate of reconstructive procedures.10–12,26 Simultaneous
oncological and reconstructive comprehensive information leads to high
rates of reconstruction and presumably reduces suboptimal, from the
oncological or plastic surgery standpoint, patient decisions.8,11,12,17,27,28
However, patient's metachronous exposure to reconstructive approaches
and education, providing the patient some time for reflection and extra
education, results in a significant rate of at least “second thoughts” or
frankly for requests of changes in the preliminary oncological plan.
Possibly, education on the aesthetic outcomes, balanced information
on the pitfalls of different procedures, and repeated exposure of the
patient to the oncological perspective, as a geographically and timely
separate encounter with another surgical consultant, all contribute to a
significant rate of changes or consideration of changes. The availability
and quality of reconstructive consults and surgical outcomes can mo-
tivate patients to modify the management plan or at least favor a spe-
cific treatment alternative.15–18 Patients whose decisional needs are
unresolved or patients who feel rushed, may ultimately delay decisions,
feel regrets and uncertainties regarding the original plans, and blame
surgeons for untoward or different-than-expected outcomes.29FIGURE 3. Patientwith lobular breast carcinoma of the left breast
treated by mastectomy with reconstruction utilizing transverse
rectus abdominis flap in 1994 could not have the same technique
for reconstruction after mastectomy for lobular right breast
carcinoma, which she developed in 2003. The right breast was
reconstructed utilizing an ipsilateral latissimus dorsi
myocutaneous flap. This patient exemplifies the notion that
symmetry of the breast appearance is easier to provide if
concurrent and same reconstructive technique is utilized.
© 2018 The Author(s). Published by Wolters Kluwer Health, Inc.Plastic surgeons are increasingly influencing the multispecialty
breast cancer management and patient decision-making process. There-
fore, each patient who plans a surgical intervention of any type, not only
mastectomy, should obtain relevant breast reconstruction information
because it may impact the choice of the oncological procedure. Patients
yearn for someone to tell them nonbiased truths. Too many times the
truth is elusive or “politically correct,” and these types of recommenda-
tions are not helpful to the patient in making the right decision.1,3,17,30
Consequently, with the recognition and appreciation of the po-
tential impact the plastic surgery specialty may exert, plastic surgeons
should be compelled to stay oncologically “literate” and be able to pro-
vide reconstructive consultations respecting the rule “Primum non
nocere.” Reconstructive surgeons should provide nonbiased education
with an awareness that even inadvertent suboptimal advice may impair
state-of-the-art breast cancer care.7,12,31,32 In particular, with the advent
of oncoplastic approaches, plastic surgeons have to appropriately coun-
sel patients and consider predictors of residual disease and high re-
excision rates (22%) after breast conservation surgery and master tumor
site/lumpectomy wound wall localization techniques.32 In addition,
plastic surgeons have to read fine prints of tests results, intercept, and
identify provisional diagnoses, because overly concerned patients may
execute an aggressive choice that could remove diagnostic precautions,
resulting in unnecessary loss of breast.33CONCLUSIONS
Plastic surgeons impact the patient's decision concerning all
oncological aspects of breast cancer care. Probably the same is true
for other nonsurgical or medical oncology specialties participating in
comprehensive breast cancer management. Therefore, multidirectional
communication between surgical and nonsurgical teammembers is crit-
ical to ensure state-of-the-art, comprehensive decisions in all aspects of
breast cancer treatment.REFERENCES
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